Skip to main content

Advertisement

SpringerLink
Log in

Adverse effects of parenteral antimicrobial therapy for chronic bone infections

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Responsible pathogens of chronic bone infections (CBI) are frequently resistant, requiring parenteral antimicrobial therapy. Therefore, adverse effects may be observed. We have determined the rate of adverse effects of antimicrobial therapy for CBI in a retrospective study of all patients receiving parenteral drugs via an implantable port. Patients from one medical ward (n = 89) and from one surgical ward (n = 40) between January 1995 and December 2005 were included in this study. The CBI included were 85 osteomyelitis (66%) and 44 prosthetic joint infections (34%). The main group of pathogens was Gram positive cocci (n = 144; 65%). The total duration of antibiotic treatment was 205 ± 200 days, including 133 ± 100 days for parenteral therapy. Thirty-three catheter-related complications were observed in 27 patients (21%). All complications led to hospitalization but none led to death. Twenty-one antibiotic-related complications occurred in 18 patients (16%), and one allergic reaction led to death. The mean duration of follow-up was 290 days. Remission was observed in 84 patients (65%). In multivariate analysis, adverse effects were mostly observed in the medical department. Adverse effects affect at least one third of the patients treated for CBI with parenteral antimicrobial therapy and are related to both the implantable port and the antibiotic compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351:1645–1654. doi:10.1056/NEJMra040181

    Article  PubMed  CAS  Google Scholar 

  2. Bernard L, Hoffmeyer P, Assal M et al (2004) Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 53:127–129. doi:10.1093/jac/dkh033

    Article  PubMed  CAS  Google Scholar 

  3. Lew DP, Waldvogel FA (2004) Osteomyelitis. Lancet 364:369–379. doi:10.1016/S0140-6736(04)16727-5

    Article  PubMed  CAS  Google Scholar 

  4. Bernard L, El H, Pron B et al (2001) Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost. J Clin Pharm Ther 26:445–451. doi:10.1046/j.1365-2710.2001.00380.x

    Article  PubMed  CAS  Google Scholar 

  5. Tice AD, Rehm SJ, Dalovisio JR et al (2004) Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis 38:1651–1672. doi:10.1086/420939

    Article  PubMed  Google Scholar 

  6. Hoffman-Terry ML, Fraimow HS, Fox TR et al (1999) Adverse effects of outpatient parenteral antibiotic therapy. Am J Med 106:44–49. doi:10.1016/S0002-9343(98)00362-3

    Article  PubMed  CAS  Google Scholar 

  7. Esposito S, Noviello S, Leone S et al (2004) Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents 24:473–478. doi:10.1016/j.ijantimicag.2004.06.004

    Article  PubMed  CAS  Google Scholar 

  8. Tice A (2001) The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the Outpatient Parenteral Antimicrobial Therapy Outcomes Registries. Chemotherapy 47(suppl 1):5–16. doi:10.1159/000048563

    Article  PubMed  CAS  Google Scholar 

  9. Galperine T, Ader F, Piriou P et al (2006) Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections. Med Mal Infect 36:132–137. doi:10.1016/j.medmal.2006.01.002

    Article  PubMed  CAS  Google Scholar 

  10. Kurul S, Saip P, Aydin T (2002) Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol 3:684–692. doi:10.1016/S1470-2045(02)00905-1

    Article  PubMed  Google Scholar 

  11. O’Grady NP, Alexander M, Dellinger EP et al (2002) Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 23:759–769. doi:10.1086/502007

    Article  PubMed  Google Scholar 

  12. Nathwani D, Tice A (2002) Ambulatory antimicrobial use: the value of an outcomes registry. J Antimicrob Chemother 49:149–154. doi:10.1093/jac/49.1.149

    Article  PubMed  CAS  Google Scholar 

  13. Barbut F, Soukouna S, Lalande V et al (2004) Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation. Pathol Biol (Paris) 52:566–574. doi:10.1016/j.patbio.2004.07.020

    CAS  Google Scholar 

  14. National Cancer Institute (2003) Cancer therapy evaluation program common terminology criteria for adverse events, version 3.0. Available at: http://ctep.cancer.gov/forms/CTCAEv3.pdf. Accessed on 10 October 2007

  15. Talfer S, Conessa C, Herve S, Roguet E, de Rotalier P, Poncet JL (2003) Complications with totally implantable venous access device. A retrospective of 116 cases. Presse Med 32:1263–1268

    Google Scholar 

  16. Hartkamp A, van Boxtel AJ, Zonnenberg BA, Witteveen PO (2000) Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med 57:215–223. doi:10.1016/S0300-2977(00)00083-8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’Infectiologie, Hôpital de l’Archet 1, Centre Hospitalier Universitaire de Nice , BP 3079, 06202, Nice, France

    C. Pulcini, T. Couadau, E. Bernard, E. Cua, V. Mondain, R.-M. Chichmanian, P. Dellamonica & P.-M. Roger

  2. Service de Chirurgie Orthopédique, Hôpital Ambroise Paré, Paris, France

    A. Lorthat-Jacob & T. Bauer

Authors
  1. C. Pulcini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Couadau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Bernard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Lorthat-Jacob
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Cua
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. V. Mondain
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R.-M. Chichmanian
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Dellamonica
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. P.-M. Roger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P.-M. Roger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pulcini, C., Couadau, T., Bernard, E. et al. Adverse effects of parenteral antimicrobial therapy for chronic bone infections. Eur J Clin Microbiol Infect Dis 27, 1227–1232 (2008). https://doi.org/10.1007/s10096-008-0570-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-008-0570-y

Keywords

Search

Navigation